Gyre Therapeutics, Inc. (GYRE) quarterly cash flow statement — complete operating, investing & financing history
Gyre Therapeutics, Inc. (GYRE) cash flow statement — 22-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -16.73M | 3.18M | -5.63M | 4.68M | 2.09M | -129K | -2.76M | 1.68M | -5.61M | 2.88M | 3.36M | 7.58M | 4.53M | 10.42M | -1.48M | -7.28M | -12.29M | -12.05M | -17.68M | -21.6M |
| Operating CF Margin % | -57.47% | 14.12% | -15.12% | 15.3% | 7.8% | -0.58% | -9.9% | 6.58% | -22.25% | 10.61% | 12.38% | 23.66% | 15.46% | 41.78% | -5.18% | -24.95% | - | -1517.63% | -724.43% | -939.54% |
| Operating CF Growth % | -901.15% | 2565.12% | -103.95% | 179% | 137.21% | -104.47% | -182.08% | -77.9% | -223.8% | -72.31% | 327.8% | 204.19% | 136.87% | 186.45% | 91.66% | 66.31% | 38.91% | 50.53% | 20.07% | -66.05% |
| Net Income | -22.99M | -8.69M | -2.4M | 5.94M | 1.58M | 3.73M | 569K | 1.12M | 3.53M | 9.94M | -100.98M | 7.51M | 3.77M | 2.24M | -40.45M | -4.88M | 51.63M | -14.54M | -20.33M | -25.24M |
| Depreciation & Amortization | 1.48M | 672K | 656K | 649K | 641K | 535K | 471K | 454K | 238K | 415K | 308K | 202K | 318K | 286K | 10K | 40K | 67K | 113K | 115K | 85K |
| Stock-Based Compensation | 2.08M | 0 | 4.6M | 1.15M | 906K | 507K | 567K | 0 | 0 | 11K | 7.28M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 683K | 713K |
| Deferred Taxes | -1.43M | -738K | 831K | -531K | -300K | -191K | -592K | 0 | -97K | -313K | -403K | -199K | -230K | -328K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -431K | 2.42M | 159K | -72K | -446K | -1.37M | -152K | 2.02M | -1.9M | -4.41M | 95.68M | 689K | 18K | 2.26M | 35.71M | 334K | -56.9M | 715K | 0 | 0 |
| Working Capital Changes | 4.56M | 9.51M | -9.47M | -2.45M | -289K | -3.35M | -3.62M | -1.93M | -7.38M | -2.76M | 1.47M | -620K | 657K | 5.95M | 3.26M | -2.77M | -7.09M | 1.66M | 1.85M | 2.84M |
| Change in Receivables | -1M | 10.47M | -9.67M | -1.19M | -2.61M | 1.52M | -5.47M | -536K | -3.28M | 1K | -1.35M | -810K | -454K | 3.92M | 0 | 0 | 564K | 1.05M | -704K | 857K |
| Change in Inventory | 94K | -1.01M | -1.21M | 72K | -954K | -1.54M | -118K | -636K | -719K | -666K | 184K | 921K | 117K | 525K | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -249K | 139K | -433K | 483K | -51K | 14K | -190K | 28K | -60K | -23K | 297K | -144K | -117K | 156K | 153K | -996K | -3.67M | -1.71M | 2.56M | 2.03M |
| Cash from Investing | 9.76M | -3.06M | 1.85M | -1.25M | -3.04M | 1.97M | -2M | -2.39M | -8.27M | -7.22M | 1.34M | -5.4M | -8.05M | -7.65M | 51K | 0 | 52.87M | 2.5M | 2.87M | 7.04M |
| Capital Expenditures | -262K | -183K | -144K | -668K | -256K | -122K | 65K | -696K | -1.46M | -231K | -2.32M | -1.97M | -2.48M | -1.81M | 2.58M | 0 | -2.58M | 0 | 0 | -492K |
| CapEx % of Revenue | 0.9% | 0.81% | 0.39% | 2.19% | 0.96% | 0.55% | 0.23% | 2.73% | 5.77% | 0.85% | 8.56% | 6.16% | 8.45% | 7.25% | 9.05% | - | - | - | - | 21.4% |
| Acquisitions | 0 | 6K | 0 | 0 | 0 | 0 | 0 | -5K | 218K | 0 | 5.02M | 0 | 0 | 0 | 51K | 0 | 55.45M | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -1.02M | 0 | -30K | -15K | -5K | -698K | -672K | 0 | 7.04M | 50K | 42K | -639K | 133K | -5.84M | -2.58M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -8K | 21K | 318K | 365K | 22.35M | 1.34M | 964K | 374K | 275K | 658K | 2.5M | 0 | 0 | 0 | 0 | -45.03M | 0 | 16K | 0 | 98K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 200K | 21K | 318K | 0 | 23M | 509K | 0 | 374K | 275K | 0 | 0 | 0 | 0 | 0 | 0 | 4K | 0 | 16K | 0 | 98K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -45.03M | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -208K | 0 | 0 | 365K | -649K | 835K | 964K | 0 | 0 | 658K | 2.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 5.79M | 431K | -3.33M | 3.91M | 21.45M | 3.23M | -4.05M | -231K | -13.69M | -3.72M | 7.43M | 2.35M | -4.42M | -13.57M | -1.42M | -52.3M | 40.58M | -9.53M | -14.81M | -14.46M |
| Free Cash Flow | -18.01M | 3M | -5.77M | 3.99M | 1.81M | -950K | -3.5M | 983K | -7.07M | 2.65M | 1.03M | 5.61M | 2.06M | 8.68M | 1.1M | -7.28M | -14.87M | -12.05M | -17.68M | -22.09M |
| FCF Margin % | -61.89% | 13.33% | -15.51% | 13.06% | 6.76% | -4.31% | -12.57% | 3.86% | -28.02% | 9.76% | 3.81% | 17.5% | 7.01% | 34.8% | 3.87% | -24.95% | - | -1517.63% | -724.43% | -960.94% |
| FCF Growth % | -1095.8% | 416% | -64.69% | 306.21% | 125.59% | -135.81% | -438.45% | -82.47% | -443.94% | -69.42% | -5.99% | 177.04% | 113.82% | 171.99% | 106.23% | 67.06% | 27.36% | 50.53% | 20.21% | -67.33% |
| FCF per Share | -0.18 | 0.03 | -0.06 | 0.04 | 0.02 | -0.01 | -0.03 | 0.01 | -0.07 | 0.03 | 0.01 | 0.07 | 0.03 | 0.12 | 0.02 | -0.12 | -0.24 | -0.19 | -0.56 | -0.70 |
| FCF Conversion (FCF/Net Income) | 1.58x | -0.37x | 3.26x | 1.30x | 4.72x | -0.05x | 27.86x | 1.49x | -1.59x | 0.38x | -0.03x | 1.91x | 2.45x | 4.64x | 0.42x | 2.18x | -0.24x | -2.39x | 0.87x | 0.86x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 687K | 447K | 3.36M | 761K | 0 | 0 | 1.44M | 0 | 1.38M | 3.54M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |